Speaker Bios
Presenters
February 20, 2007
Robert S. Conway, Ph.D.
Robert S. Conway, Ph.D. is the Worldwide Technical Marketing Director for Cuno's Healthcare group based in Meriden, Connecticut. He has been involved in filtration for pharmaceutical applications for 25 years with experience in both microfiltration and ultrafiltration systems. He is a member of the International Society of Pharmaceutical Engineers (ISPE) and the Parenteral Drug Association (PDA) and serves on the Filtration Committee. Dr. Conway received his Ph.D. degree in Microbiology and Biochemistry from Emory University School of Medicine in Atlanta, Georgia. He has numerous publications in the area of filtration and has been an instructor at the Center for Professional Advancement.
Charles L. Cooney, Ph.D.
Charles L. Cooney, Ph.D. is Professor of Chemical and Biochemical Engineering, in the Department of Chemical Engineering. He is the Faculty Director of the Deshpande Center for Technological Innovation, Co-Director of the Program on the Pharmaceutical Industry (POPI) and MIT faculty director of the Consortium on Advanced Manufacturing for Pharmaceuticals (CAMP). He obtained his Bachelor's degree in Chemical Engineering from the University of Pennsylvania in 1966. His Master's and Ph.D. degrees in Biochemical Engineering are from MIT in 1967, and 1970, respectively. After a short post-doctoral time at the Squibb Institute for Medical Research in 1970, he joined the faculty of MIT as an Assistant Professor in 1970 and became a full Professor in 1982. He received the 1989 Gold Medal of the Institute of Biotechnological Studies (London), the Food, Pharmaceutical and Bioengineering Award from the American Institute of Chemical Engineers and the James Van Lanen Distinguished Service Award from the American Chemical Society's Division of Microbial and Biochemical Technology and was elected to the American Institute of Medical and Biochemical Engineers. He serves as a consultant to a number of biotech and pharmaceutical companies, is on several editorial boards of professional journals, sits on the Boards of Directors of Genzyme, BioProcessors and Biocon, Ltd (India), is a member of the BP Technical Advisory Council and is chair of the FDA Advisory Committee for Pharmaceutical Science.
Prof. Cooney's research interests span a range of topics in biochemical engineering and pharmaceutical manufacturing. He has published over 300 research papers, over 30 patents and co-authored or edited 4 books. He has particular interest in bioreactor design, operation and control, downstream processing for recovery of biological products, processing of pharmaceutical powders and manufacturing strategy in the pharmaceutical and biotech industry. The central philosophy underlying research in his laboratory is the application of multidisciplinary approaches to the development of advanced manufacturing technologies for the biochemical and pharmaceutical industry. As faculty director of the Deshpande Center he is interested in the process of stimulating technological innovation and translating innovation into new company creation.
In addition to his professional interests, Prof. Cooney is a Trustee of Boston Ballet, and an Overseer of the Boston Symphony Orchestra. His other interests include rock climbing, skiing, high altitude mountaineering (with assents of Denali, Ama Dablam, Mont Blanc, Huascaran), scuba diving and antique map collecting.
Lisa Crossley, Ph.D., P.Eng.
Lisa Crossley, Ph.D., P.Eng., is the President & CEO of Nysa Membrane Technologies, a biotech start up company based in the Toronto, Ontario, Canada Area. Lisa's background is in the field of biochemical engineering and biopharmaceutical manufacturing. Lisa left a faculty position in the Department of Chemical Engineering at McMaster University to join Nysa in March, 2005. Prior to joining the faculty at McMaster she worked in Product Development at Dyax Corporation in Boston, MA, where she directed the process development, technology transfer, and large-scale clinical-grade contract manufacturing of one of Dyax's lead therapeutic proteins. In this position she managed multi-disciplinary teams of scientists and engineers at contract analytical labs and manufacturing organizations in Europe, the U.S. and Canada and worked closely with the FDA and other international regulatory agencies. Lisa has consulted for several of North America's largest Life Sciences Venture Capital companies, aiding in technical due diligence as well as designing comprehensive product development plans for early-stage portfolio companies. Lisa holds a B.Sc. in Anatomy & Cell Biology from McGill University, as well as a B.Sc.E. and Ph.D. in Chemical Engineering from Queen's University. She received her post-doctoral training in the BioProcess Sector of the National Research Council of Canada's Biotechnology Research Institute in Montreal. Lisa is a licensed Professional Engineer in the province of Ontario.
Alexander A. Di Iorio, Ph.D.
Alexander A. Di Iorio, Ph.D. is the Director of the Bioprocessing Center at WPI and an Affiliate Assistant Professor. Dr. Di Iorio has more than 20 years experience in the field of fermentation technology. He has consulted for several companies in fields ranging from stem cell technology to biomanufacturing of recombinant products. He holds a B.S. degree in Chemical Engineering from Columbia University, a M.S. in Biotechnology and a Ph.D. in Biochemical Engineering from WPI.
Parrish M. Galliher
Parrish M. Galliher earned his BA in Biology at Boston University (1975) and earned his MS in Biochemical Engineering at MIT (1981). Mr. Galliher joined Biogen, Inc. in 1981 where he was responsible for design, commissioning and management of Biogen's first biomanufacturing facilities for both E.coli and mammalian cell manufacturing. As Director of Process Engineering, he led the team responsible for startup, initial validation and commissioning of Biogen's Avonex® manufacturing facility, later licensed by the FDA in 1996. Mr. Galliher joined Alpha-Beta Technology (ABT) in 1994 as Director of Manufacturing Development and led the technology transfer, startup, validation, and commissioning of ABT's 55,000 sq ft. biopharmaceutical manufacturing plant in Smithfield, RI at which he became Vice President of Operations and General Manager in 1997. Mr. Galliher joined LeukoSite, Inc. in 1999 as Vice President of Biologics Manufacturing and continued in that role after Millennium Pharmaceuticals acquired LeukoSite. At Millennium, Mr. Galliher led the CMC Team that contributed to FDA and EU licensure of CAMPATH® monoclonal antibody in 2001. He also led the Biologics Manufacturing Productivity Improvement Program which enabled high speed development of Millennium's monoclonal antibodies for clinical trials. In December 2002, Mr. Galliher became Founder, President and CEO of Xcellerex, an advanced technology contract biomanufacturing company. In December 2004, Mr. Galliher transitioned to President and Chief Technology Officer of Xcellerex, Inc.
Warren E. Schwartz, Ph.D.
Warren E. Schwartz, Ph.D. serves as Senior Technical Director for Pall Life Sciences and is responsible for technical support of sorbent products in North America.
Prior to joining Pall Corporation, Dr. Schwartz served in senior technical-support positions with other leading manufacturers of sorbents and related products for process scale purification of biomolecules. Experienced in both analytical and preparative-scale chromatography and separations science, Dr. Schwartz served as research scientist and Principal Investigator with Battelle Laboratories, Columbus, Ohio, where he led a variety of contract-research programs. He also served as Senior Scientist and Group Leader, Purification Process Development at Hybridon, Cambridge, Massachusetts.
Dr. Schwartz received a Ph.D. degree in biochemistry from The Ohio State University and a B.S. degree in chemistry from the City University of New York.
Registration | Abstracts/Presentations | Speaker Bios
Maintained by webmaster@wpi.eduLast modified: April 18, 2007 13:55:26